Войти в систему Зарегистрироваться бесплатно

Akari Therapeutics Plc Доход

Что обозначает Доход в Akari Therapeutics Plc?

Доход Akari Therapeutics Plc является -$18.10

Какое определение для Доход?

Чистая прибыль, подлежащая распределению среди обычных акционеров, равна чистой прибыли за вычетом выплаченных привилегированных дивидендов.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Доход компаний в Health Care сектор на NASDAQ по сравнению с Akari Therapeutics Plc

Что делает Akari Therapeutics Plc?

akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.

Компании с доход похож на Akari Therapeutics Plc